MYO10 (Myosin X) is an unconventional myosin motor protein highly expressed in human satellite glial cells (SGCs) that plays a critical role in mitochondrial transfer to neurons. Disruption of this pathway leads to nerve degeneration and neuropathic pain, making it a novel therapeutic target for neurodegeneration. This mechanism represents a fundamental metabolic support system in the peripheral nervous system with implications for understanding and treating various neurological conditions [1].
The discovery of MYO10-mediated mitochondrial transfer has revealed a previously unrecognized pathway for neuronal metabolic support. Unlike central nervous system astrocytes which transfer mitochondria through various mechanisms, peripheral sensory neurons rely heavily on SGC-derived mitochondrial support for maintaining metabolic homeostasis [2]. This distinction has important implications for understanding peripheral neuropathies and developing targeted therapies.
MYO10 belongs to the unconventional myosin family, characterized by motor activity that uses ATP to generate force along actin filaments. Unlike conventional myosins that primarily function in muscle contraction and cellular transport, MYO10 possesses unique structural features that enable its specialized functions:
The motor activity of MYO10 is particularly suited for long-range transport along actin filaments, with step sizes and running velocities that exceed other myosin family members [3]. This enables efficient mitochondrial trafficking across the relatively long processes of SGCs that extend to wrap around neuronal cell bodies.
MYO10 demonstrates remarkable specificity in its expression pattern:
This expression pattern has significant research implications, as findings in murine models may not fully translate to human physiology without considering the MYO10 species difference [4].
Satellite glial cells (SGCs) are specialized glial cells that ensheath sensory neurons in peripheral ganglia (dorsal root ganglia, trigeminal ganglia). They provide metabolic support and communicate with neurons through various mechanisms, including direct mitochondrial transfer. Each sensory neuron in peripheral ganglia is surrounded by multiple SGCs that form a tight envelope, creating a unique microdomain for neuron-glia communication [5].
The SGC-neuron relationship in peripheral ganglia parallels the astrocyte-neuron relationship in the CNS but with distinct mechanistic features. SGCs respond to neuronal activity, undergo morphological changes, and provide feedback to neurons through various signaling molecules including ATP, glutamate, and cytokines [6].
MYO10 is a motor protein that:
The transfer process involves several key steps:
Mitochondrial Recruitment: MYO10 localizes to mitochondria through interactions with adaptor proteins including miro1 and milton, which serve as bridging molecules connecting mitochondria to motor proteins [7]
Actin-Based Transport: MYO10 walks along actin filaments, moving mitochondria from the SGC soma toward the SGC-neuron interface
Intercellular Transfer: The actual transfer likely occurs through direct cytoplasmic connections or tunneling nanotubes (TNTs), though the precise mechanism remains under investigation [8]
Neuronal Integration: Transferred mitochondria integrate into the neuronal mitochondrial network, contributing to ATP production and calcium buffering
While MYO10 research has focused primarily on peripheral nervous system disorders, the fundamental mechanisms have implications for AD:
The mitochondrial dysfunction paradigm in PD intersects with SGC-mitochondrial transfer:
ALS affects both central and peripheral nervous systems:
The MYO10 pathway is most directly relevant to peripheral neuropathy:
| Condition | MYO10 Pathway Relevance |
|---|---|
| Diabetic Neuropathy | Hyperglycemia impairs SGC mitochondrial transfer |
| Chemotherapy-induced | Taxanes and platinum drugs disrupt mitochondrial dynamics |
| Chronic Inflammatory | Inflammatory cytokines affect SGC function |
| Hereditary | Some inherited neuropathies involve mitochondrial dysfunction |